Article
Changing interpretation of chromosomal microarray over time in a community cohort with intellectual disability.
American journal of medical genetics. Part A - 1 Feb 2014
Palmer Emma, Speirs Helen, Taylor Peter J, Mullan Glenda, Turner Gill, Einfeld Stewart, Tonge Bruce, Mowat David
Abstract excerpt
Chromosomal microarray (CMA) is the first-line diagnostic test for individuals with intellectual disability, autism, or multiple congenital anomalies, with a 10-20% diagnostic yield. An ongoing challenge for the clinician and laboratory scientist is the interpretation of variants of uncertain significance (VOUS)-usually rare, unreported genetic variants. Laboratories differ in their threshold for reporting VOUS,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
